Amoxicillin can be used in patients with hematological malignancies, but close monitoring for infections and interactions with other treatments is vital.

Amoxicillin is generally safe for use in patients with hematological malignancies, but it requires careful management of dosage and monitoring for potential side effects.

When prescribing amoxicillin to patients with hematological malignancies, clinicians must monitor renal function and blood counts to mitigate risks of toxicity and infection.